Brokerages Set HCA Healthcare, Inc. (NYSE:HCA) PT at $391.27

Shares of HCA Healthcare, Inc. (NYSE:HCA) have earned a consensus rating of “Moderate Buy” from the seventeen analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $385.27.

Several brokerages have issued reports on HCA. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Barclays lowered their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd.

Insider Buying and Selling at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Institutional Trading of HCA Healthcare

Several institutional investors have recently made changes to their positions in HCA. MML Investors Services LLC increased its stake in HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after buying an additional 4,285 shares during the last quarter. Meritage Group LP bought a new stake in HCA Healthcare during the third quarter worth $150,548,000. Alpha DNA Investment Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $869,000. NRI Wealth Management LC purchased a new position in shares of HCA Healthcare in the 4th quarter worth about $2,896,000. Finally, Chiron Investment Management LLC bought a new stake in HCA Healthcare in the third quarter worth about $3,548,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $308.55 on Friday. The stock has a market capitalization of $78.15 billion, a PE ratio of 13.85, a P/E/G ratio of 1.21 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a fifty day simple moving average of $324.68 and a 200 day simple moving average of $354.48. HCA Healthcare has a 1-year low of $276.50 and a 1-year high of $417.14.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.